• ISSCR Founder Leonard Zon talks about the development and growth of the ISSCR and

    Leonard Zon

    ISSCR Founder

  • Munsie and Young 50p

    Understanding the Clinical Applications of MSCs

    Megan Munsie, PhD, University of Melbourne and Mark Young, MBBS, FACSEP, University of Queensland

  • Moustapha Kassem 2

    'Know Thy Cell' - Rigorous Assays for the Characterization of MSCs

    Moustapha Kassem, MD, PhD, University Hospital of Odense

  • Pamela Robey

    Tissue Specific Stem / Progenitor Cells Known as MSCS

    Pamela Robey, PhD, National Institutes of Health

  • Frey-Vasconcells and Xu 2

    Cell Therapy Regulations in the U.S.

    Joyce Frey-Vansconcells, PhD, Frey-Vasconcells Consultants LLC and Lei Xu, MD, PhD, U.S. FDA

  • Yoji_Sato_Photo

    Japan's Regulatory Framework for Expedited Clinical Application of Cell-Based Therapeutic Products

    Yoji Sato, PhD, National Institutes of Health Sciences (Japan)

  • Shingleton and Mullen 2

    Using Imaging Technologies to Understand Mechanism of Action, Safety and Efficacy of Cellular Therapies

    Bill Shingleton, PhD, GE Healthcare and Greg Mullen, PhD, King's College London

  • Arcidiacono and Lin-Gibson 15 June 2016 2

    Developing Standards for Cell Therapy and Regenerative Medicine

    Judith Arcidiacono, MS, U.S. FDA and Sheng Lin-Gibson, PhD, National Institute of Standards and Technology (U.S.)

  • Finn and Harris 20 April 2016_3

    Cell Therapy Process Development and Process Changes

    Ian Harris, PhD, Janssen Research and Development, LLC and Thomas Finn, PhD, U.S. FDA

  • Lebkowski and Wu no logo sm2

    Preclinical Development for Cell Therapy Products

    Jane Lebkowski, PhD, Asterias Therapeutics and Iwen Wu, PhD, U.S. FDA